| LINE ITEM (USD / %) | FY 2025
FILED 2026-01-31 | FY 2024
FILED 2025-01-31 | FY 2023
FILED 2024-01-31 |
|---|---|---|---|
| Revenue (Total Sales) | $961.0M | $771.9M | $614.3M |
| YoY Revenue Growth % | +24.5% | +25.6% | — |
| Gross Profit | $673.7M | $500.9M | — |
| Gross Margin % | 70.1% | 64.9% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$169.2M | -$230.0M | -$182.9M |
| Operating Margin % | -17.6% | -29.8% | -29.8% |
| Net Income (GAAP) | -$159.9M | -$239.1M | -$195.1M |
| EBITDA (Normalized) | -$165.4M | -$226.9M | -$160.7M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $110.1M | $37.1M | -$39.7M |
| Capital Expenditures (CapEx) | $4.7M | $3.8M | $27.6M |
| Free Cash Flow (FCF) | $105.4M | $33.3M | -$67.3M |
| FCF Margin % | 11.0% | 4.3% | -11.0% |
| Return on Invested Capital (ROIC %) | -11.2% | -16.3% | -5.6% |
| Cash & Short-Term Equivalents | $428.8M | $441.8M | — |
| Total Debt (Short + Long Term) | $98.9M | $104.0M | $1.00B |
| Total Stockholders' Equity | $1.53B | $1.45B | $2.06B |